A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...
The RNA analysis market is poised for significant growth due to rising demand in precision medicine, advancements in NGS technologies, and expanding use of RNA biomarkers in diagnostics and drug ...
The study highlights a presymptomatic phase in type 1 diabetes progression, using immune niches to track immune changes ...
Rutgers Develops New Tool for Examining Cancer Genomic Data that Could Improve Treatment When scientists sequence tumor DNA, ...
Artificial intelligence (AI) is now an essential tool in biopharma manufacturing, yet industry still needs guidelines on how LLMs, ML, and other technologies should be used in drug making, say the ...
Hippocampi- targeted AAV-delivered BDNF gene therapy improves cognitive impairments in Alzheimer’s disease Alzheimer’s ...
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
QIAsprint Connect marks entry into high-throughput sample processing, enabling labs to scale workflows with flexible ...
Researchers reprogrammed bacterial bridge recombinases to edit large genomic regions in mammalian cells, revealing a ...
Industry leaders outline how advances in MS, affinity platforms, sample preparation, AI-driven analysis, and data standardization are transforming proteomics. These innovations are enabling deeper and ...
"By cleverly combining new techniques for analyzing DNA at the level of individual molecules, we can achieve real breakthroughs in research into conditions such as dementia," predicts Professor John ...
AZoLifeSciences on MSN
Overcoming endosomal escape in oligonucleotide drug delivery
This study addresses endosomal escape in oligonucleotide therapies and how engineered peptides can enhance intracellular drug delivery efficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results